HEART TRONICS INC

HEART TRONICS INC

OOTC:HRTT
0.00
USD
0.00
(0.00%)
No data availableFinancial data will appear here once available

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Company Description

CEO
James N. Fiedler
Full Time Employees
13
Sector
Health technology
Industry
Medical specialties
Address
4705 Laurel Canyon Boulevard Van Nuys CA United States 91607
IPO Date
Apr 29, 1997
Business
Heart Tronics, Inc. Heart Tronics, Inc. (HRTT) is a medical device company that engages in the research, development, and marketing of devices designed to monitor and measure physiological signals for detecting cardiovascular diseases and related health conditions in the United States. The company offers the Fidelity 100 Monitor System, an FDA 510(k)-cleared Class II device comprising the Model 100 Patient Module for collecting, processing, and amplifying electrocardiogram (ECG) signals via 10 electrodes, wireless transmission capabilities, electrode lead sets, and proprietary software-operated laptop computers for signal interpretation and storage; this system produces high-fidelity ECG signals suitable for ambulatory and noisy environments. Founded in 1987 and headquartered in Van Nuys, California, Heart Tronics, Inc. previously operated as Signalife Inc. and focuses on cardiovascular monitoring solutions for patients exhibiting heart disease symptoms, with no reported revenue in recent periods and ongoing operations in the health technology sector's medical specialties segment.